Cyclic nucleotide signalling in kidney fibrosis

Elisabeth Schinner1, Veronika Wetzl2, Jens Schlossmann3

  • 1Pharmacology and Toxicology, University Regensburg, Regensburg 93053, Germany. elisabeth.schinner@chemie.uni-regensburg.de.

Insights

Cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) show potential in suppressing kidney fibrosis. Understanding their mechanisms may lead to new treatments for kidney disease progression and failure.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pharmacology

Background:

  • Kidney fibrosis is a key driver of progressive kidney diseases, including diabetic nephropathy, glomerulosclerosis, and nephritis.
  • Chronic kidney disease and end-stage renal disease are often the result of unchecked renal fibrosis.
  • Cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) have demonstrated protective effects against various kidney diseases.

Purpose of the Study:

  • To summarize the known effects and mechanisms of cAMP and cGMP in the context of renal fibrosis.
  • To explore potential therapeutic strategies targeting these cyclic nucleotide pathways for kidney disease treatment.

Main Methods:

  • This review synthesizes existing research on the roles of cAMP and cGMP in renal fibrosis.
  • It examines signaling pathways involved, including the nitric oxide/guanylyl cyclase/cGMP-dependent protein kinase pathway and the cAMP/Epac/adenylyl cyclase/cAMP-dependent protein kinase pathway.
  • Potential pharmacological agents that activate these pathways are discussed.

Main Results:

  • cAMP and cGMP signaling pathways play significant roles in modulating renal fibrosis.
  • Specific pathways identified include those involving nitric oxide, ANP, guanylyl cyclases, and protein kinases.
  • Diverse drug targets that modulate these pathways have been identified.

Conclusions:

  • The intricate mechanisms of cAMP and cGMP offer promising avenues for therapeutic intervention in kidney fibrosis.
  • Targeting these pathways could lead to novel pharmacological treatments for the prevention and therapy of kidney failure.
  • Further research into these pathways may revolutionize the management of progressive kidney diseases.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
2
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
55.6K
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
69.8K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
5.1K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
652
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.1K